{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T13:45:49Z","timestamp":1764510349296},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Hematol Malig Rep"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1007\/s11899-008-0023-9","type":"journal-article","created":{"date-parts":[[2008,10,9]],"date-time":"2008-10-09T23:31:03Z","timestamp":1223595063000},"page":"161-166","source":"Crossref","is-referenced-by-count":8,"title":["Acute lymphoblastic leukemia in adolescents and young adults"],"prefix":"10.1007","volume":"3","author":[{"given":"Elly V.","family":"Barry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lewis B.","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,10,10]]},"reference":[{"key":"23_CR1","volume-title":"Cancer Epidemiology in Older Adolescents and Young Adults 15\u201329 Years of Age, Including SEER Incidence and Survival: 1975\u20132000","author":"L.A. Mattano Jr","year":"2006","unstructured":"Mattano LA Jr, Nachman J, Ross J, et al.: Leukemias. In: Cancer Epidemiology in Older Adolescents and Young Adults 15\u201329 Years of Age, Including SEER Incidence and Survival: 1975\u20132000. Edited by Bleyer A, O\u2019Leary M, Barr R, Ries LAG. Bethesda, MD: National Cancer Institute; 2006. [NIH publication no. 06-5767.]"},{"key":"23_CR2","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1182\/blood-2006-06-027714","volume":"109","author":"A. Moghrabi","year":"2007","unstructured":"Moghrabi A, Levy DE, Asselin B, et al.: Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia. Blood 2007, 109:896\u2013904.","journal-title":"Blood"},{"key":"23_CR3","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1182\/blood-2004-04-1616","volume":"104","author":"C.H. Pui","year":"2004","unstructured":"Pui CH, Sandlund JT, Pei D, et al.: Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children\u2019s Research Hospital. Blood 2004, 104:2690\u20132696.","journal-title":"Blood"},{"key":"23_CR4","first-page":"3310","volume":"95","author":"M. Schrappe","year":"2000","unstructured":"Schrappe M, Reiter A, Ludwig WD, et al.: Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group. Blood 2000, 95:3310\u20133322.","journal-title":"Blood"},{"key":"23_CR5","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1038\/sj.leu.2401973","volume":"14","author":"M. Schrappe","year":"2000","unstructured":"Schrappe M, Reiter A, Zimmermann M, et al.: Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Munster. Leukemia 2000, 14:2205\u20132222.","journal-title":"Leukemia"},{"key":"23_CR6","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1038\/sj.leu.2401939","volume":"14","author":"P.S. Gaynon","year":"2000","unstructured":"Gaynon PS, Trigg ME, Heerema NA, et al.: Children\u2019s Cancer Group trials in childhood acute lymphoblastic leukemia: 1983\u20131995. Leukemia 2000, 14:2223\u20132233.","journal-title":"Leukemia"},{"key":"23_CR7","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1200\/JCO.2000.18.3.547","volume":"18","author":"H.M. Kantarjian","year":"2000","unstructured":"Kantarjian HM, O\u2019Brien S, Smith TL, et al.: Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia. J Clin Oncol 2000, 18:547\u2013561.","journal-title":"J Clin Oncol"},{"key":"23_CR8","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1182\/blood.V99.3.863","volume":"99","author":"L. Annino","year":"2002","unstructured":"Annino L, Vegna ML, Camera A, et al.: Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study. Blood 2002, 99:863\u2013871.","journal-title":"Blood"},{"key":"23_CR9","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1200\/JCO.2004.10.050","volume":"22","author":"X. Thomas","year":"2004","unstructured":"Thomas X, Boiron JM, Huguet F, et al.: Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial. J Clin Oncol 2004, 22:4075\u20134086.","journal-title":"J Clin Oncol"},{"key":"23_CR10","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/cncr.11664","volume":"98","author":"S. Faderl","year":"2003","unstructured":"Faderl S, Jeha S, Kantarjian HM: The biology and therapy of adult acute lymphoblastic leukemia. Cancer 2003, 98:1337\u20131354.","journal-title":"Cancer"},{"key":"23_CR11","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/sj.leu.2400959","volume":"12","author":"J.M. Chessells","year":"1998","unstructured":"Chessells JM, Hall E, Prentice HG, et al.: The impact of age on outcome in lymphoblastic leukaemia; MRC UKALL X and XA compared: a report from the MRC Paediatric and Adult Working Parties. Leukemia 1998, 12:463\u2013473.","journal-title":"Leukemia"},{"key":"23_CR12","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1055\/s-2005-872515","volume":"217","author":"A. Moricke","year":"2005","unstructured":"Moricke A, Zimmermann M, Reiter A, et al.: Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95. Klin Padiatr 2005, 217:310\u2013320.","journal-title":"Klin Padiatr"},{"key":"23_CR13","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1200\/JCO.2006.08.6397","volume":"25","author":"E. Barry","year":"2007","unstructured":"Barry E, DeAngelo DJ, Neuberg D, et al.: Favorable outcome for adolescents with acute lymphoblastic leukemia treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Protocols. J Clin Oncol 2007, 25:813\u2013819.","journal-title":"J Clin Oncol"},{"key":"23_CR14","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1038\/sj.leu.2401129","volume":"12","author":"R. Pieters","year":"1998","unstructured":"Pieters R, den Boer ML, Durian M, et al.: Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia\u2014implications for treatment of infants. Leukemia 1998, 12:1344\u20131348.","journal-title":"Leukemia"},{"key":"23_CR15","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1182\/blood.V99.4.1253","volume":"99","author":"C. Nyvold","year":"2002","unstructured":"Nyvold C, Madsen HO, Ryder LP, et al.: Precise quantification of minimal residual disease at day 29 allows identification of children with acute lymphoblastic leukemia and an excellent outcome. Blood 2002, 99:1253\u20131258.","journal-title":"Blood"},{"key":"23_CR16","doi-asserted-by":"crossref","first-page":"308a","DOI":"10.1182\/blood-2004-01-0145","volume":"104","author":"J. Zhou","year":"2004","unstructured":"Zhou J, Li A, Goldwasser M, et al.: Quantitative analysis of minimal residual disease at the completion of induction therapy predicts relapse in children with B-lineage acute lymphoblastic leukemia in DFCI ALL Consortium protocol 95-01 [abstract]. Blood 2004, 104:308a.","journal-title":"Blood"},{"key":"23_CR17","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1182\/blood-2002-04-1130","volume":"100","author":"E. Coustan-Smith","year":"2002","unstructured":"Coustan-Smith E, Sancho J, Hancock ML, et al.: Use of peripheral blood instead of bone marrow to monitor residual disease in children with acute lymphoblastic leukemia. Blood 2002, 100:2399\u20132402.","journal-title":"Blood"},{"key":"23_CR18","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1002\/(SICI)1097-0142(19971101)80:9<1717::AID-CNCR4>3.0.CO;2-B","volume":"80","author":"P.S. Gaynon","year":"1997","unstructured":"Gaynon PS, Desai AA, Bostrom BC, et al.: Early response to therapy and outcome in childhood acute lymphoblastic leukemia: a review. Cancer 1997, 80:1717\u20131726.","journal-title":"Cancer"},{"key":"23_CR19","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1038\/sj.leu.2401980","volume":"14","author":"L.B. Silverman","year":"2000","unstructured":"Silverman LB, Declerck L, Gelber RD, et al.: Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981\u20131995). Leukemia 2000, 14:2247\u20132256.","journal-title":"Leukemia"},{"key":"23_CR20","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1200\/JCO.1996.14.1.18","volume":"14","author":"M. Smith","year":"1996","unstructured":"Smith M, Arthur D, Camitta B, et al.: Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol 1996, 14:18\u201324.","journal-title":"J Clin Oncol"},{"key":"23_CR21","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(05)66998-X","volume":"366","author":"A. Balduzzi","year":"2005","unstructured":"Balduzzi A, Valsecchi MG, Uderzo C, et al.: Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: comparison by genetic randomisation in an international prospective study. Lancet 2005, 366:635\u2013642.","journal-title":"Lancet"},{"key":"23_CR22","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1182\/blood-2007-10-116582","volume":"111","author":"A.H. Goldstone","year":"2008","unstructured":"Goldstone AH, Richards SM, Lazarus HM, et al.: In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation\/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII\/ECOG E2993). Blood 2008, 111:1827\u20131833.","journal-title":"Blood"},{"key":"23_CR23","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1200\/JCO.2003.02.053","volume":"21","author":"N. Boissel","year":"2003","unstructured":"Boissel N, Auclerc MF, Lheritier V, et al.: Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials. J Clin Oncol 2003, 21:774\u2013780.","journal-title":"J Clin Oncol"},{"key":"23_CR24","first-page":"467a","volume":"96","author":"W. Stock","year":"2000","unstructured":"Stock W, Sather H, Dodge RK, et al.: Outcome of adolscents and young adults with ALL: a comparison of Children\u2019s Cancer Group (CCG) and Cancer and Leukemia Group B (CALGB) regimens [abstract]. Blood 2000; 96:467a.","journal-title":"Blood"},{"key":"23_CR25","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1038\/sj.leu.2403538","volume":"18","author":"J.M. Bont de","year":"2004","unstructured":"de Bont JM, Holt B, Dekker AW, et al.: Significant difference in outcome for adolescents with acute lymphoblastic leukemia treated on pediatric vs adult protocols in the Netherlands. Leukemia 2004, 18:2032\u20132035.","journal-title":"Leukemia"},{"key":"23_CR26","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/cncr.22189","volume":"107","author":"H. Hallbook","year":"2006","unstructured":"Hallbook H, Gustafsson G, Smedmyr B, et al.: Treatment outcome in young adults and children >10 years of age with acute lymphoblastic leukemia in Sweden: a comparison between a pediatric protocol and an adult protocol. Cancer 2006, 107:1551\u20131561.","journal-title":"Cancer"},{"key":"23_CR27","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/pbc.20749","volume":"48","author":"R. Ramanujachar","year":"2007","unstructured":"Ramanujachar R, Richards S, Hann I, et al.: Adolescents with acute lymphoblastic leukaemia: outcome on UK national paediatric (ALL97) and adult (UKALLXII\/E2993) trials. Pediatr Blood Cancer 2007, 48:254\u2013261.","journal-title":"Pediatr Blood Cancer"},{"key":"23_CR28","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1200\/JCO.2007.13.7265","volume":"26","author":"J.M. Ribera","year":"2008","unstructured":"Ribera JM, Oriol A, Sanz MA, et al.: Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the Programa Espanol de Tratamiento en Hematologia pediatric-based protocol ALL-96. J Clin Oncol 2008, 26:1843\u20131849.","journal-title":"J Clin Oncol"},{"key":"23_CR29","doi-asserted-by":"crossref","first-page":"181a","DOI":"10.1182\/blood.V110.11.587.587","volume":"110","author":"D.J. DeAngelo","year":"2007","unstructured":"DeAngelo DJ, Dahlberg S, Silverman LB, et al.: A multicenter phase II study using a dose intensified pediatric regimen in adults with untreated acute lymphoblastic leukemia [abstract]. Blood 2007, 110:181a.","journal-title":"Blood"},{"key":"23_CR30","doi-asserted-by":"crossref","first-page":"48a","DOI":"10.1182\/blood.V108.11.147.147","volume":"108","author":"F. Huguet","year":"2006","unstructured":"Huguet F, Raffoux E, Thomas X, et al.: Towards a pediatric approach in adults with acute lymphoblastic leukemia (ALL) [abstract]. Blood 2006, 108:48a.","journal-title":"Blood"},{"key":"23_CR31","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1002\/cncr.20532","volume":"101","author":"J.E. Rubnitz","year":"2004","unstructured":"Rubnitz JE, Lensing S, Zhou Y, et al.: Death during induction therapy and first remission of acute leukemia in childhood: the St. Jude experience. Cancer 2004, 101:1677\u20131684.","journal-title":"Cancer"},{"key":"23_CR32","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1365-2141.2005.05544.x","volume":"130","author":"J. Nachman","year":"2005","unstructured":"Nachman J: Clinical characteristics, biologic features and outcome for young adult patients with acute lymphoblastic leukaemia. Br J Haematol 2005, 130:166\u2013173.","journal-title":"Br J Haematol"},{"key":"23_CR33","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1200\/JCO.2000.18.18.3262","volume":"18","author":"L.A. Mattano Jr","year":"2000","unstructured":"Mattano LA Jr, Sather HN, Trigg ME, et al.: Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children\u2019s Cancer Group. J Clin Oncol 2000, 18:3262\u20133272.","journal-title":"J Clin Oncol"},{"key":"23_CR34","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1200\/JCO.2001.19.12.3066","volume":"19","author":"A.J. Strauss","year":"2001","unstructured":"Strauss AJ, Su JT, Dalton VM, et al.: Bony morbidity in children treated for acute lymphoblastic leukemia. J Clin Oncol 2001, 19:3066\u20133072.","journal-title":"J Clin Oncol"},{"key":"23_CR35","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/pbc.20244","volume":"44","author":"B. Burger","year":"2005","unstructured":"Burger B, Beier R, Zimmermann M, et al.: Osteonecrosis: a treatment related toxicity in childhood acute lymphoblastic leukemia (ALL)\u2014experiences from trial ALL-BFM 95. Pediatr Blood Cancer 2005, 44:220\u2013225.","journal-title":"Pediatr Blood Cancer"},{"key":"23_CR36","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/sj.leu.2405032","volume":"22","author":"B. Patel","year":"2008","unstructured":"Patel B, Richards SM, Rowe JM, et al.: High incidence of avascular necrosis in adolescents with acute lymphoblastic leukaemia: a UKALL XII analysis. Leukemia 2008, 22:308\u2013312.","journal-title":"Leukemia"},{"key":"23_CR37","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1365-2141.2005.05528.x","volume":"129","author":"U.H. Athale","year":"2005","unstructured":"Athale UH, Siciliano SA, Crowther M, et al.: Thromboembolism in children with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute protocols: effect of age and risk stratification of disease. Br J Haematol 2005, 129:803\u2013810.","journal-title":"Br J Haematol"}],"container-title":["Current Hematologic Malignancy Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-008-0023-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11899-008-0023-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-008-0023-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T01:42:59Z","timestamp":1588988579000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11899-008-0023-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["23"],"URL":"https:\/\/doi.org\/10.1007\/s11899-008-0023-9","relation":{},"ISSN":["1558-8211","1558-822X"],"issn-type":[{"value":"1558-8211","type":"print"},{"value":"1558-822X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}